Eptifibatide dosage forms and strengths

Eptifibatide
INTEGRILIN® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Eptifibatide
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

dosage forms and strengths

• Injection: 20 mg of INTEGRILIN in 10 mL (2 mg/mL), for intravenous bolus
• Injection: 75 mg of INTEGRILIN in 100 mL (0.75 mg/mL), for intravenous infusion.
• Injection: 200 mg of INTEGRILIN in 100 mL (2 mg/mL), for intravenous infusion.